Prothena Corporation plc PRTA

Updated: 9 Aug 2026

NASDAQ | Biotech | Biotechnology / drug development

No signal published yet

We already track Prothena and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Prothena free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology / drug development
We're already tracking Prothena Corporation plc — here are the latest events we've registered

Recent News

  • On August 6, 2026, Prothena reported its second quarter 2026 financial results, highlighting a net loss of $18.6 million compared to $125.8 million in the second quarter of 2025. The company held $289.1 million in cash, cash equivalents, and restricted cash as of June 30, 2026. Prothena also updated its guidance to project a year-end cash balance of approximately $259 million.

What Firelda Watch includes for Prothena Corporation plc

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Prothena Corporation plc will be delivered in the same format.

Want to follow Prothena Corporation plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Prothena free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Prothena Corporation plc PRTA
Prothena — follow and we'll monitor it
Follow Prothena free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.